Who We Are
Leadership
Partnership
Our Science
Therapeutic Areas
Duchenne
Hunter Syndrome
EGPA
Scientific Approach
Exon-Skipping
Gene Therapy
Selective JAK1 Inhibition
Pipeline & Products
Products
Clinical Trials
Newsroom
Events & Posters
Press Releases
Careers
Our Culture
Contact Us
Events & posters
Explore an archive of our poster presentations and data releases.
ESC Congress
August 28-31, 2026
Phase 1 Safety, Tolerability, and Pharmacokinetics of NS-863 Supporting Development for Pulmonary Arterial Hypertension and Pulmonary Hypertension Associated with Interstitial Lung Disease
View Poster
MDA Clinical & Scientific Conference
March 8-11, 2026
An Open-Claims Data Set Analysis to Evaluate the Persistence of Viltolarsen, an Exon-Skipping Therapy, in Patients With Duchenne Muscular Dystrophy
View Poster
MDA Clinical & Scientific Conference
March 8-11, 2026
A Phase 1/2 Study Of NS-050/NCNP-03, An Investigational Exon 50 Skipping Therapy, In Boys With Duchenne Muscular Dystrophy (Meteor50): Trial Design
View Poster
AANEM Annual Meeting
October 29- November 1, 2025
Persistence of Viltolarsen, an Exon-Skipping Therapy, in Patients With Duchenne Muscular Dystrophy Using an Open-Claims Data Set
View Poster
MDA Clinical & Scientific Conference
March 16-19, 2025
Four-Year Patient Experience on Viltolarsen
View Poster
MDA Clinical & Scientific Conference
March 3-6, 2024
Pulmonary and motor function in ambulatory and nonambulatory participants with Duchenne muscular dystrophy treated with viltolarsen
View Poster
MDA Clinical & Scientific Conference
March 3-6, 2024
Brogidirsen, an investigational exon 44 skipping agent for the treatment of Duchenne muscular dystrophy: Clinical trial design (Phase 2)
View Poster
MDA Clinical & Scientific Conference
March 19-22, 2023
Results of a 4-Year Viltolarsen Extension Study of Functional and Safety Outcomes
View Poster
